‹ Back
Retatrutide · What it helps
Blood sugar and insulin
GLP-1 and GIP make insulin release follow the glucose in the blood. The after-meal spike flattens and fasting sugar falls. Even with glucagon in the mix, glucose stays steady because the two incretin arms balance it. Insulin sensitivity rises as liver and muscle fat clear.
Sources
Read the original sources
- LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. (Coskun · 2022 · Abstract; full methods not assumed · checked 2026-10-13)
- Type 2 diabetes and obesity: the present and future of incretin therapy, Shestakova and Bashlykova 2025, Therapeutic Archive (Russia) (Summary · checked 2026-10-13)